Cite
Novel GLP-1R/GIPR co-agonist “twincretin” is neuroprotective in cell and rodent models of mild traumatic brain injury.
MLA
Tamargo, Ian A., et al. “Novel GLP-1R/GIPR Co-Agonist ‘Twincretin’ Is Neuroprotective in Cell and Rodent Models of Mild Traumatic Brain Injury.” Experimental Neurology, vol. 288, Feb. 2017, pp. 176–86. EBSCOhost, https://doi.org/10.1016/j.expneurol.2016.11.005.
APA
Tamargo, I. A., Bader, M., Li, Y., Yu, S.-J., Wang, Y., Talbot, K., DiMarchi, R. D., Pick, C. G., & Greig, N. H. (2017). Novel GLP-1R/GIPR co-agonist “twincretin” is neuroprotective in cell and rodent models of mild traumatic brain injury. Experimental Neurology, 288, 176–186. https://doi.org/10.1016/j.expneurol.2016.11.005
Chicago
Tamargo, Ian A., Miaad Bader, Yazhou Li, Seong-Jin Yu, Yun Wang, Konrad Talbot, Richard D. DiMarchi, Chaim G. Pick, and Nigel H. Greig. 2017. “Novel GLP-1R/GIPR Co-Agonist ‘Twincretin’ Is Neuroprotective in Cell and Rodent Models of Mild Traumatic Brain Injury.” Experimental Neurology 288 (February): 176–86. doi:10.1016/j.expneurol.2016.11.005.